q2 earnings per share $30.32.
q2 non-gaap earnings per share $3.54.
q2 sales rose 33.4 percent to $715.9 million.
sees q2 non-gaap sales growth in range of 13% to 14% excluding covid-related sales.
sees fy non-gaap currency neutral revenue growth of 10% to 10.5%.
sees fy covid-related sales to be between $200 million and $210 million.
qtrly sales increased 27.5% on a currency neutral basis.
q2 sales rose 34.3 percent to $380.2 million.